Found 6 matching trials
Study to Assess the Safety, Tolerability, PK, ECG Effects, Food Effect, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers PHASE1 This trial will consist of three parts: the first two parts will enroll hea...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis PHASE1 This trial will consist of three arms: Part A, Part B, and Part C. Part A h...
Show More Location
Stanford University Medical Center
Learn More & Join Trial
Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis PHASE2 The study population is comprised of adult subjects with cystic fibrosis (C...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis PHASE1 The study is a randomized, double-blind, placebo-controlled, study that wil...
Show More Learn More & Join Trial
Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO® as Background Therapy PHASE1 The trial will consist of a single treatment group enrolling adult subjects...
Show More Learn More & Join Trial
Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis PHASE1 Part 1 of this trial will enroll healthy volunteers into a single ascending...
Show More Location
Banner University of Arizona Medical Center
Learn More & Join Trial